Filing Details
- Accession Number:
- 0001225208-12-017773
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-14 16:18:58
- Reporting Period:
- 2012-08-10
- Filing Date:
- 2012-08-14
- Accepted Time:
- 2012-08-14 16:18:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428698 | Brian Daniels | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Svp Global Dev & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2012-08-10 | 71,556 | $17.51 | 135,921 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2012-08-10 | 5,989 | $23.14 | 141,910 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2012-08-10 | 79,900 | $31.72 | 62,010 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2012-08-10 | 71,556 | $0.00 | 71,556 | $17.51 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2012-08-10 | 5,989 | $0.00 | 5,989 | $23.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,852 | 2019-03-02 | No | 4 | M | Direct | |
| 0 | 2004-03-04 | 2013-03-03 | No | 4 | M | Direct |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $31.70 to $31.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Twenty-five percent of the stock option award vested on each of the first, second, and third anniversaries of the grant date, which was March 3, 2009. The remainder of the stock option award will vest on March 3, 2013, the fourth anniversary of the grant date.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2003.
Billionaire Hedge Funds
